Pharming Group N.V. (PHAR)

11.23USD -2.01% (-0.23)

Over 1M: +2.6%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

11 11.5 12
7 Aug 12 Aug 17 Aug 20 Aug 25 Aug 28 Aug 2 Sep

Financials Annual

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
FY21 — Revenue: 198.9M FY21 — Operating Income: 13.6M FY21 — Net Income: 16M FY22 — Revenue: 205.6M FY22 — Operating Income: 18.2M FY22 — Net Income: 13.7M FY23 — Revenue: 245.3M FY23 — Operating Income: -5.4M FY23 — Net Income: -10.5M FY24 — Revenue: 297.2M FY24 — Operating Income: -8.6M FY24 — Net Income: -11.8M FY25 — Revenue: 376.1M FY25 — Operating Income: 25.8M FY25 — Net Income: 2.5M 0 80M 160M 240M 320M 400M
FY21 FY22 FY23 FY24 FY25
Revenue Operating Income Net Income

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

3.9
SBC / sales 3.7%
OE margin 10.7%
Adj. EBITDA margin 10.9%
ROIC 13.7%
Oper. margin 6.9%
Accruals -10.4%
Capex / sales 0.2%
Gross margin 87.9%
OCF / EBIT 2.1×
Asset turnover 0.75×
FCF margin 14.3%
OCF margin 14.5%
ROCE 6.7%
EBITDA margin 7.2%
Profit margin 0.67%
ROA 0.51%
ROE 0.92%

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

1.0
EV/EBIT 604.9×
EV/OE 388.9×
FCF yield 0.34%
EV/GP 47.3×
EV/Sales 41.6×
P/B 56.9×
P/C 108.5×
P/E 6209.5×
Div. yield —
Fwd P/E —
PEG —
Shareholder yield —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

4.7
Gross margin stability across years 1.2 pp
Revenue growth in the worst year on record -6.3%
Cash-flow margin stability 14.9 pp
Prepaid revenue growth —
RPO / sales —
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

9.1
Interest cover 131.8×
ND/EBITDA 0.0082
Current ratio 2.6×
Cash / Debt 8.2×
Debt / Eq 0.064×
Debt payback 0.0 yr
Net debt / Eq 0.0×
Payout 0.0%
Equity / Assets 55.4%
F-score 6.8 pts
Quick ratio 2.0×
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

5.3
Most recent margin move 9.2
Sales/sh Y/Y +33.1%
Operating margin trend 0.013
Sales CAGR 4Y +17.3%
Gross profit Y/Y +26.3%
Shares change -4.9%
EBIT CAGR +17.5%
EPS CAGR 4Y -35.4%
Div. growth —
EBIT Y/Y —
EPS Y/Y —
EPS next Y —
Sales Q/Q —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.